pneumonia
lead
caus
childhood
morbid
mortal
global
introduct
conjug
haemophilu
influenza
b
multival
pneumococc
vaccin
develop
countri
includ
australia
significantli
reduc
overal
burden
bacteri
pneumonia
avail
molecular
diagnost
virus
frequent
detect
children
pneumonia
either
primari
pathogen
predispos
secondari
bacteri
infect
mani
respiratori
pathogen
known
caus
pneumonia
also
identifi
asymptomat
children
true
contribut
pathogen
childhood
communityacquir
pneumonia
cap
remain
unclear
sinc
introduct
pneumococc
vaccin
comprehens
studi
develop
countri
attempt
determin
bacteri
viral
aetiolog
pneumonia
aim
determin
contribut
bacteria
virus
childhood
cap
inform
develop
effect
diagnosi
treatment
prevent
strategi
conduct
prospect
casecontrol
studi
pneumowa
case
children
radiologicallyconfirm
pneumonia
admit
princess
margaret
hospit
children
pmh
control
healthi
children
identifi
pmh
outpati
clinic
local
commun
immunis
clinic
casecontrol
ratio
children
recruit
arm
nasopharyng
swab
np
collect
case
control
detect
presenc
virus
bacteria
polymeras
chain
reaction
pcr
pathogen
load
assess
quantit
pcr
preval
pathogen
detect
case
control
compar
odd
ratio
detect
popul
attribut
fraction
cap
pathogen
determin
relationship
pathogen
load
diseas
statu
sever
explor
studi
approv
human
research
ethic
committe
pmh
perth
australia
pmh
hrec
ref
find
dissemin
research
confer
peerreview
journal
strength
first
casecontrol
studi
australia
determin
aetiolog
rel
contribut
respiratori
virus
bacteria
childhood
pneumonia
post
pneumococc
vaccin
era
studi
design
estim
much
respiratori
pathogen
attribut
childhood
pneumonia
popul
level
adjust
demograph
factor
preexist
chronic
medic
condit
presenc
respiratori
pathogen
prospect
recruit
frequenc
match
case
control
age
group
adjust
effect
age
particip
pathogen
season
caus
pneumonia
children
case
defin
children
radiologicallyconfirm
pneumonia
reduc
interobserv
variabl
defin
pneumonia
basi
respiratori
symptom
present
hospit
standard
definit
pneumonia
increas
generaliz
studi
data
limit
specimen
detect
respiratori
virus
bacteria
collect
actual
site
infect
ie
lower
respiratori
tract
therefor
would
difficult
conclud
detect
pathogen
caus
diseas
howev
evid
pathogen
nasopharynx
found
associ
lower
respiratori
tract
infect
therefor
nasopharyng
specimen
suitabl
meet
studi
object
pneumonia
lead
caus
morbid
mortal
among
young
children
global
recent
estim
suggest
approxim
million
new
case
communityacquir
pneumonia
cap
occur
year
nearli
million
death
among
children
age
year
death
occur
low
resourc
set
burden
childhood
cap
develop
countri
lower
approxim
case
per
childrenyear
howev
cap
remain
import
public
health
concern
increas
antibacteri
resist
evid
replac
diseas
nonvaccin
strain
emerg
new
respiratori
pathogen
australia
cap
import
caus
hospit
children
hospitalis
per
childyear
children
year
old
western
australia
incid
especi
high
aborigin
children
observ
time
higher
risk
hospitalis
cap
nonaborigin
children
identif
caus
microorgan
childhood
cap
remain
ongo
challeng
affect
type
clinic
specimen
obtain
test
method
use
previou
studi
use
varieti
specimen
identifi
caus
pathogen
childhood
pneumonia
includ
bronchoalveolar
lung
fluid
blood
nasopharyng
aspir
nasopharyng
swab
pleural
fluid
complic
case
varieti
respiratori
virus
bacteria
associ
childhood
cap
develop
countri
tabl
pathogen
fungi
includ
endem
mycos
less
common
caus
cap
histor
bacteria
consid
import
caus
cap
children
global
prior
introduct
pneumococc
conjug
vaccin
develop
countri
earli
streptococcu
pneumonia
pneumococcu
lead
bacteri
pathogen
caus
cap
identifi
young
children
cap
bacteria
associ
childhood
pneumonia
includ
encapsul
nontyp
haemophilu
influenza
streptococcu
pyogen
staphylococcu
aureu
moraxella
catarrhali
gramneg
enter
bacteria
atyp
intracellular
bacteria
exampl
mycoplasma
pneumonia
chlamydophila
pneumonia
also
report
caus
childhood
cap
pneumonia
appear
detect
commonli
among
schoolag
younger
children
burden
bacteri
pneumonia
reduc
significantli
europ
unit
state
australia
sinc
introduct
conjug
haemophilu
influenza
b
multival
pneumococc
conjug
vaccin
pcv
routin
immun
schedul
howev
bacteria
still
remain
import
caus
pneumonia
mani
develop
set
vaccin
introduc
recent
introduc
develop
frequent
use
molecular
diagnost
respiratori
virus
increasingli
detect
among
children
pneumonia
particularli
children
year
old
among
virus
respiratori
syncyti
viru
rsv
influenza
viru
human
parainfluenza
viru
hpiv
human
rhinoviru
hrv
human
adenoviru
hadv
commonli
detect
children
pneumonia
new
sensit
molecular
techniqu
enabl
detect
new
respiratori
virus
includ
human
metapneumoviru
hmpv
novel
human
coronavirus
hcov
human
bocaviru
hbov
emerg
strain
influenza
viru
childhood
cap
develop
countri
young
children
cap
virus
detect
respiratori
specimen
rsv
frequent
detect
viru
studi
rang
evid
respiratori
virus
may
role
facilit
bacteri
colonis
enhanc
bacteri
infect
andor
enhanc
diseas
sever
either
directli
indirectli
virus
disrupt
respiratori
epithelium
barrier
also
alter
defenc
mechan
host
epithelium
potenti
lead
bacteri
entranc
enabl
secondari
bacteri
infect
incid
invas
pneumococc
infect
observ
higher
increas
season
activ
respiratori
virus
includ
influenza
rsv
parainfluenza
adenoviru
clinic
trial
south
africa
conjug
pneumococc
vaccin
result
overal
decreas
virusassoci
pneumonia
suggest
interact
respiratori
virus
pneumococcu
caus
pneumonia
children
australia
ecolog
data
demonstr
reduct
viral
pneumonia
follow
introduct
pcv
vaccin
fathima
p
et
al
cid
patient
viralbacteri
coinfect
report
suffer
treatment
failur
longer
ventil
support
increas
likelihood
intens
care
unit
admiss
relationship
nasopharyng
pathogen
load
diseas
sever
previous
assess
data
sever
pneumonia
epidemiolog
studi
studi
demonstr
nasopharyng
pathogen
load
could
predict
sever
pneumonia
children
studi
us
among
infant
report
higher
rsv
load
associ
longer
hospit
respiratori
failur
admiss
intens
care
unit
vietnam
children
radiolog
confirm
pneumonia
higher
pneumococc
load
compar
children
respiratori
ill
load
pneumococcu
higher
children
viral
coinfect
compar
viral
coinfect
studi
kenya
netherland
report
higher
nasopharyng
rsv
load
children
sever
respiratori
infect
compar
less
sever
infect
despit
number
studi
develop
countri
design
explor
aetiolog
acut
respiratori
infect
children
includ
cap
includ
healthyasymptomat
children
control
studi
includ
healthi
control
identifi
asymptomat
presenc
pathogen
known
associ
pneumonia
tabl
addit
epidemiolog
studi
similar
set
nasopharyng
carriag
respiratori
bacteria
virus
known
associ
pneumonia
also
report
healthi
children
togeth
find
suggest
asymptomat
carriag
may
common
healthi
popul
therebi
make
interpret
cap
studi
challeng
although
pneumococc
conjug
vaccin
success
reduc
hospit
rate
cap
children
develop
countri
pneumococcu
remain
import
pathogen
emerg
nonvaccin
serotyp
potenti
caus
sever
complic
pneumonia
empyema
mani
case
associ
respiratori
virus
tabl
current
immun
strategi
focuss
exclus
bacteri
pneumonia
expect
modest
impact
pneumonia
case
reduct
apart
annual
influenza
vaccin
date
licens
vaccin
respiratori
virus
use
commun
critic
understand
rel
contribut
specif
bacteri
viral
pathogen
childhood
cap
help
inform
develop
new
therapeut
pneumonia
includ
antivir
support
ongo
effort
new
prevent
strategi
vaccin
target
rsv
parainfluenza
advanc
stage
develop
question
constitut
primari
aim
studi
addit
unveil
relationship
pathogen
load
pathogen
inform
tool
accur
attribut
infect
caus
cap
allow
better
diagnosi
manag
pneumonia
case
use
antibiot
antivir
therapi
final
studi
identifi
emerg
serotyp
pneumococcu
caus
cap
among
vaccin
children
inform
design
futur
pneumococc
vaccin
swedish
studi
rel
underpow
xray
confirm
case
control
assess
attribut
risk
rang
viral
pathogen
us
studi
healthi
control
enrol
contemporan
studi
site
might
bias
infer
specif
pathogen
propos
studi
first
casecontrol
studi
pneumonia
aetiolog
australia
postpcv
vaccin
era
radiolog
confirm
hospit
pneumonia
case
compar
agegroup
frequenc
match
healthi
control
presenc
respiratori
pathogen
quantit
load
pathogen
propos
studi
expect
address
limit
previou
casecontrol
studi
recruit
appropri
number
case
control
contemporan
studi
site
aim
studi
determin
contribut
bacteri
viral
respiratori
pathogen
cap
among
west
australian
children
primari
object
assess
pathogen
respiratori
virus
bacteria
pathogenspecif
populationattribut
risk
radiologicallyproven
cap
children
secondari
object
determin
frequenc
respiratori
virusbacteri
coinfect
children
cap
compar
healthi
children
assess
contribut
coinfect
clinic
outcom
sever
compar
nasopharyng
viral
bacteri
load
children
cap
compar
healthi
children
assess
import
pathogen
load
diseas
statu
sever
identifi
nasopharyng
quantit
threshold
pathogen
optim
discrimin
sensit
specif
children
cap
asymptomat
children
prospect
casecontrol
studi
name
pneumowa
studi
casecontrol
ratio
children
attend
publicli
fund
health
servic
metropolitan
perth
western
australia
recruit
enrol
children
studi
commenc
princess
margaret
hospit
children
pmh
perth
western
australia
may
case
control
enrol
follow
inclus
exclus
criteria
studi
tabl
case
defin
children
attend
pmh
cap
identifi
treat
clinician
oper
definit
pneumonia
studi
presenc
one
follow
clinic
symptom
cough
fever
increas
work
breath
b
alveolar
consolid
judg
treat
clinician
c
presum
infect
aetiolog
requir
antibiot
therapi
control
group
consist
contemporan
healthi
children
attend
pmh
outpati
clinic
local
commun
immunis
clinic
sign
respiratori
ill
total
case
control
enrol
power
studi
detect
significantli
higher
rate
pathogen
detect
among
case
versu
control
depend
frequenc
pathogen
detect
healthi
control
use
data
previous
publish
literatur
among
pneumonia
case
healthi
control
estim
sampl
size
pneumonia
case
healthi
control
would
provid
power
identifi
signific
excess
pathogen
detect
lower
bound
confid
interv
among
case
compar
control
rang
least
influenza
rhinoviru
case
identifi
daili
monitor
present
emerg
depart
ed
admiss
record
pmh
assess
inclus
exclus
criteria
parent
approach
train
research
assist
consent
enrol
follow
data
biolog
specimen
collect
control
enrol
prospect
contemporan
train
research
staff
attend
pmh
outpati
clinic
rheola
street
immunis
clinic
perth
western
australia
parent
approach
whilst
await
child
medic
appoint
routin
immun
control
frequenc
match
case
age
group
year
year
year
year
prospect
set
target
control
enrol
base
number
case
enrol
age
group
preced
two
week
follow
consent
epidemiolog
data
relat
pertin
demograph
factor
age
sex
indigen
statu
presenc
smoker
household
prematur
birth
preexist
chronic
health
condit
immunodefici
neurolog
disord
chronic
cardiac
diseas
collect
studi
particip
tabl
use
standard
paperbas
data
collect
form
interview
parent
data
clinic
manag
diseas
outcom
case
obtain
review
hospit
medic
record
patient
medic
record
file
revisit
obtain
miss
medic
inform
ill
episod
immun
record
child
collect
australian
immun
record
air
particip
alloc
uniqu
identif
number
allow
anonym
data
enter
onto
secur
webbas
research
databas
nasopharyng
swab
np
collect
case
control
use
floqswab
copan
diagnost
murrieta
ca
usa
train
research
staff
follow
recommend
procedur
collect
swab
store
skim
milktryptoneglucoseglycerol
broth
stggb
suitabl
storag
transport
respiratori
bacteria
virus
collect
np
specimen
kept
ice
process
within
research
laboratori
pmh
children
clinic
research
facil
ccrf
np
specimen
vortex
second
divid
two
aliquot
bacteri
viral
assess
vial
store
specimen
batch
period
sent
refer
laboratori
pcr
test
np
specimen
transport
refer
laboratori
ice
day
test
avoid
addit
freezethaw
cycl
np
test
viral
presenc
load
pathwest
laboratori
medicin
wa
perth
australia
bacteri
load
research
laboratori
school
biomed
scienc
univers
western
australia
perth
western
australia
respiratori
virus
atyp
bacteri
pathogen
mycoplasma
pneumonia
chlamydophila
pneumonia
detect
multiplex
realtim
polymeras
chain
reaction
pcr
pathwest
laboratori
qeii
use
previous
describ
primer
probe
detail
nucleic
acid
extract
np
use
magna
pure
system
roch
appli
scienc
indianapoli
us
extract
nucleic
acid
test
appli
biosystem
realtim
pcr
quantit
viral
load
assess
np
specimen
posit
respiratori
virus
primer
probe
protocol
determin
viral
load
rang
viral
pathogen
np
specimen
develop
pathwest
sikazw
c
et
al
unpublish
data
nucleic
acid
standard
develop
use
purifi
plasmid
dna
vitro
transcrib
rna
concentr
dna
andor
rna
standard
quantifi
use
fluoresc
dye
follow
standard
curv
gener
serial
dilut
dna
andor
rna
standard
mention
viral
load
np
specimen
quantifi
interpol
appropri
standard
curv
viral
load
report
viral
copiesml
quantif
bacteri
load
np
specimen
perform
use
quantit
real
time
pcr
qpcr
use
method
establish
uwa
school
biomed
scienc
kirkham
l
et
al
unpublish
data
np
stgg
centrifug
high
speed
pellet
bacteria
associ
cell
dna
extract
pellet
use
enzymat
extract
qiaamp
dna
minikit
qiagen
chadston
vic
australia
previous
describ
realtim
qpcr
detect
pneumonia
aureu
catarrhali
nontyp
h
influenza
conduct
realtim
pcr
detect
system
biorad
ca
usa
use
primer
probe
list
tabl
standard
curv
gener
run
refer
strain
sampl
run
duplic
densiti
calcul
averag
two
measur
bacteri
load
assess
coloni
form
unit
cfu
ml
equival
copiesml
assum
one
copi
bacteria
would
yield
one
coloni
form
unit
frequenc
proport
posit
respiratori
pathogen
among
case
control
assess
number
permit
viru
subtyp
report
separ
proport
compar
across
two
group
identifi
specif
pathogen
detect
frequent
among
case
among
control
report
crude
oddsratio
detect
respiratori
pathogen
among
cap
case
versu
control
also
report
adjust
odd
ratio
pathogen
adjust
demograph
factor
eg
age
sex
presenc
smoker
household
prematur
birth
presenc
pathogen
use
multivari
logist
regress
refer
model
adjust
oddsratio
detect
among
case
versu
control
taken
indic
pathogen
organ
higher
oddsratio
higher
indic
pathogen
microorgan
use
proport
case
infect
adjust
oddsratio
pathogen
popul
level
attributablefract
cap
calcul
use
method
greenland
drescher
frequenc
proport
case
control
coinfect
one
respiratori
viru
bacteria
report
number
permit
multivari
regress
model
develop
explor
exist
signific
pairwis
interact
respiratori
pathogen
diseas
statu
diseas
sever
case
assess
use
respiratori
index
sever
children
score
risc
base
australian
children
growth
standard
number
permit
explor
relationship
detect
specif
pathogen
pathogen
coinfect
sever
diseas
versu
control
statu
use
multivari
logist
regress
model
describ
model
model
report
median
logtransform
pathogen
load
pathogen
case
control
compar
use
student
ttest
mannwhitney
utest
method
whichev
applic
determin
pathogen
load
differ
case
control
multivari
regress
analysi
model
perform
determin
odd
case
log
increas
pathogen
loadml
viral
bacteri
pathogen
adjust
demograph
factor
number
permit
approach
use
determin
increas
odd
sever
pneumonia
versu
control
statu
model
explor
receiveroper
curv
roc
correspond
area
curv
auc
find
optim
load
cutpoint
sensit
specif
discrimin
cap
case
control
sever
cap
nonsever
cap
pathogen
also
analys
data
use
classif
regress
tree
cart
bayesian
network
method
altern
approach
select
threshold
level
pathogen
load
discrimin
case
control
analys
perform
use
stata
softwar
version
statacorp
texa
usa
studi
approv
human
research
ethic
committe
princess
margaret
hospit
children
perth
australia
pmh
hrec
ref
written
inform
consent
obtain
parent
assent
children
year
prior
administr
questionnair
biolog
specimen
collect
risk
benefit
relat
particip
studi
clearli
inform
parent
children
obtain
consent
uniqu
identif
number
provid
particip
ensur
anonym
inform
collect
studi
particip
remain
confidenti
payment
compens
associ
particip
find
dissemin
nation
intern
confer
health
symposium
manuscript
detail
result
studi
submit
public
peerreview
journal
find
studi
would
describ
attribut
risk
specif
viral
bacteri
pathogen
caus
childhood
pneumonia
popul
level
might
help
effici
diagnosi
manag
lower
respiratori
tract
infect
lrti
includ
pneumonia
children
could
reduc
inappropri
antibiot
treat
lrti
fund
studi
provid
telethon
perth
children
hospit
research
fund
perth
children
hospit
foundat
telethon
kid
institut
none
ccb
conceiv
studi
tl
pcr
aj
rt
lk
dw
contribut
develop
mub
rw
implement
studi
activ
mlb
assist
recruit
laboratori
test
undertaken
tr
jl
cs
mub
draft
manuscript
author
review
manuscript
give
sourc
fund
role
funder
present
studi
applic
origin
studi
present
articl
base
give
inform
separ
case
control
casecontrol
studi
applic
expos
unexpos
group
cohort
crosssect
studi
introduct
pneumonia
lead
caus
childhood
morbid
mortal
global
introduct
conjug
haemophilu
influenza
b
multival
pneumococc
vaccin
develop
countri
includ
australia
significantli
reduc
overal
burden
bacteri
pneumonia
avail
molecular
diagnost
virus
frequent
detect
children
pneumonia
either
primari
pathogen
predispos
secondari
bacteri
infect
mani
respiratori
pathogen
known
caus
pneumonia
also
identifi
asymptomat
children
true
contribut
pathogen
childhood
communityacquir
pneumonia
cap
remain
unclear
sinc
introduct
pneumococc
vaccin
comprehens
studi
develop
countri
attempt
determin
bacteri
viral
aetiolog
pneumonia
aim
determin
contribut
bacteria
virus
childhood
cap
inform
develop
effect
diagnosi
treatment
prevent
strategi
conduct
prospect
casecontrol
studi
pneumowa
case
children
radiologicallyconfirm
pneumonia
admit
princess
margaret
hospit
children
pmh
control
healthi
children
identifi
pmh
outpati
clinic
local
commun
immunis
clinic
casecontrol
ratio
children
recruit
arm
nasopharyng
swab
np
collect
case
control
detect
presenc
virus
bacteria
polymeras
chain
reaction
pcr
pathogen
load
assess
quantit
pcr
preval
pathogen
detect
case
control
compar
odd
ratio
detect
popul
attribut
fraction
cap
pathogen
determin
relationship
pathogen
load
diseas
statu
sever
explor
studi
approv
human
research
ethic
committe
pmh
perth
australia
pmh
hrec
ref
find
dissemin
research
confer
peerreview
journal
strength
first
casecontrol
studi
australia
determin
aetiolog
rel
contribut
respiratori
virus
bacteria
childhood
pneumonia
post
pneumococc
vaccin
era
studi
design
estim
much
respiratori
pathogen
attribut
childhood
pneumonia
popul
level
adjust
demograph
factor
preexist
chronic
medic
condit
presenc
respiratori
pathogen
prospect
recruit
frequenc
match
case
control
age
group
adjust
effect
age
pathogen
season
caus
pneumonia
children
case
defin
children
radiologicallyconfirm
pneumonia
reduc
interobserv
variabl
increas
generaliz
studi
data
limit
specimen
detect
respiratori
virus
bacteria
collect
upper
respiratori
tract
nasopharynx
instead
actual
site
infect
ie
lower
respiratori
tract
pathogen
detect
nasopharyng
swab
necessarili
confirm
presenc
pathogen
lower
respiratori
tract
howev
evid
pathogen
nasopharynx
found
associ
lower
respiratori
tract
infect
children
previou
epidemiolog
studi
occur
year
nearli
million
death
among
children
age
year
death
occur
low
resourc
set
burden
childhood
cap
develop
countri
lower
approxim
case
per
childrenyear
howev
cap
remain
import
public
health
concern
increas
antibacteri
resist
evid
replac
diseas
nonvaccin
strain
emerg
new
respiratori
pathogen
australia
cap
import
caus
hospit
children
hospitalis
per
childyear
children
year
old
western
australia
incid
especi
high
aborigin
children
observ
time
higher
risk
hospitalis
cap
nonaborigin
children
identif
caus
microorgan
childhood
cap
remain
ongo
challeng
affect
type
clinic
specimen
obtain
test
method
use
previou
studi
use
varieti
specimen
identifi
caus
pathogen
childhood
pneumonia
includ
bronchoalveolar
lung
fluid
blood
nasopharyng
aspir
nasopharyng
swab
pleural
fluid
complic
case
varieti
respiratori
virus
bacteria
associ
childhood
cap
develop
countri
tabl
pathogen
fungi
includ
endem
mycos
less
common
caus
cap
histor
bacteria
consid
import
caus
cap
children
global
prior
introduct
pneumococc
conjug
vaccin
develop
countri
earli
streptococcu
pneumonia
pneumococcu
lead
bacteri
pathogen
caus
cap
identifi
young
children
cap
bacteria
associ
childhood
pneumonia
includ
encapsul
nontyp
haemophilu
influenza
streptococcu
pyogen
staphylococcu
aureu
moraxella
catarrhali
gramneg
enter
bacteria
atyp
intracellular
bacteria
exampl
mycoplasma
pneumonia
chlamydophila
pneumonia
also
report
caus
childhood
cap
pneumonia
appear
detect
commonli
among
schoolag
younger
children
burden
bacteri
pneumonia
reduc
significantli
europ
unit
state
australia
sinc
introduct
conjug
haemophilu
influenza
b
multival
pneumococc
conjug
vaccin
pcv
routin
immun
schedul
howev
bacteria
still
remain
import
caus
pneumonia
mani
develop
set
vaccin
introduc
recent
introduc
develop
frequent
use
molecular
diagnost
respiratori
virus
increasingli
detect
among
children
pneumonia
particularli
children
year
old
among
virus
respiratori
syncyti
viru
rsv
influenza
viru
human
parainfluenza
viru
hpiv
human
rhinoviru
hrv
human
adenoviru
hadv
commonli
detect
children
pneumonia
new
sensit
molecular
techniqu
enabl
detect
new
respiratori
virus
includ
human
metapneumoviru
hmpv
novel
human
coronavirus
hcov
human
bocaviru
hbov
emerg
strain
influenza
viru
childhood
cap
develop
countri
young
children
cap
virus
detect
respiratori
specimen
rsv
frequent
detect
viru
studi
rang
evid
respiratori
virus
may
role
facilit
bacteri
colonis
enhanc
bacteri
infect
andor
enhanc
diseas
sever
either
directli
indirectli
virus
disrupt
respiratori
epithelium
barrier
also
alter
defenc
mechan
host
epithelium
potenti
lead
bacteri
entranc
enabl
secondari
bacteri
infect
incid
invas
pneumococc
infect
observ
higher
increas
season
activ
respiratori
virus
includ
influenza
rsv
parainfluenza
f
r
p
e
e
r
r
e
v
e
w
n
l
adenoviru
clinic
trial
south
africa
conjug
pneumococc
vaccin
result
overal
decreas
virusassoci
pneumonia
suggest
interact
respiratori
virus
pneumococcu
caus
pneumonia
children
australia
ecolog
data
demonstr
reduct
viral
pneumonia
follow
introduct
pcv
vaccin
rsv
report
facilit
bacteri
colon
haemophilu
influenza
streptococcu
pyogen
staphylococcu
aureu
moraxella
catarrhali
nasopharynx
young
children
acut
respiratori
infect
anoth
studi
australia
identifi
streptococcu
pneumonia
haemophilu
influenza
staphylococcu
aureu
patient
intens
care
admit
sever
influenza
infect
influenza
pandem
patient
viralbacteri
coinfect
report
suffer
treatment
failur
longer
ventil
support
increas
likelihood
intens
care
unit
admiss
relationship
nasopharyng
pathogen
load
diseas
sever
previous
assess
data
sever
pneumonia
epidemiolog
studi
studi
demonstr
nasopharyng
pathogen
load
could
predict
sever
pneumonia
children
studi
us
among
infant
report
higher
rsv
load
associ
longer
hospit
respiratori
failur
admiss
intens
care
unit
vietnam
children
radiolog
confirm
pneumonia
higher
pneumococc
load
compar
children
respiratori
ill
load
pneumococcu
higher
children
viral
coinfect
compar
viral
coinfect
studi
kenya
netherland
report
higher
nasopharyng
rsv
load
children
sever
respiratori
infect
compar
less
sever
infect
despit
number
studi
develop
countri
design
explor
aetiolog
acut
respiratori
infect
children
includ
cap
includ
healthyasymptomat
children
control
studi
includ
healthi
control
identifi
asymptomat
presenc
pathogen
known
associ
pneumonia
tabl
addit
epidemiolog
studi
similar
set
nasopharyng
carriag
respiratori
bacteria
virus
known
associ
pneumonia
also
report
healthi
children
togeth
find
suggest
asymptomat
carriag
may
common
healthi
popul
therebi
make
interpret
cap
studi
challeng
although
pneumococc
conjug
vaccin
success
reduc
hospit
rate
cap
children
develop
countri
pneumococcu
remain
import
pathogen
emerg
nonvaccin
serotyp
potenti
caus
sever
complic
pneumonia
empyema
mani
case
associ
respiratori
virus
tabl
current
immun
strategi
focuss
exclus
bacteri
pneumonia
expect
modest
impact
pneumonia
case
reduct
apart
annual
influenza
vaccin
date
licens
vaccin
respiratori
virus
use
commun
critic
understand
rel
contribut
specif
bacteri
viral
pathogen
childhood
cap
help
inform
develop
new
therapeut
pneumonia
includ
antivir
support
ongo
effort
new
prevent
strategi
vaccin
target
rsv
parainfluenza
advanc
stage
develop
question
constitut
primari
aim
studi
addit
unveil
relationship
pathogen
load
pathogen
inform
tool
accur
attribut
infect
caus
cap
allow
better
diagnosi
manag
pneumonia
case
use
antibiot
antivir
therapi
final
studi
identifi
emerg
serotyp
pneumococcu
caus
cap
among
vaccin
children
inform
design
futur
pneumococc
vaccin
detect
microorgan
asymptomat
children
make
challeng
ascertain
exact
contribut
pathogen
diseas
uncontrol
pneumonia
aetiolog
studi
cap
casecontrol
studi
children
develop
countri
generaliz
develop
countri
swedish
studi
rel
underpow
xray
confirm
case
control
assess
attribut
risk
rang
viral
pathogen
us
studi
healthi
control
enrol
contemporan
studi
site
might
bias
infer
specif
pathogen
propos
studi
first
casecontrol
studi
pneumonia
aetiolog
australia
postpcv
vaccin
era
radiolog
confirm
hospit
pneumonia
case
compar
agegroup
frequenc
match
healthi
control
presenc
respiratori
pathogen
quantit
load
pathogen
propos
studi
expect
address
limit
previou
casecontrol
studi
recruit
appropri
number
case
control
contemporan
studi
site
aim
studi
determin
contribut
bacteri
viral
respiratori
pathogen
cap
among
west
australian
children
primari
object
assess
pathogen
respiratori
virus
bacteria
pathogenspecif
populationattribut
risk
radiologicallyproven
cap
children
secondari
object
determin
frequenc
respiratori
virusbacteri
coinfect
children
cap
compar
healthi
children
assess
contribut
coinfect
clinic
outcom
sever
compar
nasopharyng
viral
bacteri
load
children
cap
compar
healthi
children
assess
import
pathogen
load
diseas
statu
sever
identifi
nasopharyng
quantit
threshold
pathogen
optim
discrimin
sensit
specif
children
cap
asymptomat
children
prospect
casecontrol
studi
name
pneumowa
studi
casecontrol
ratio
children
attend
publicli
fund
health
servic
metropolitan
perth
western
australia
recruit
enrol
children
studi
commenc
princess
margaret
hospit
children
pmh
perth
western
australia
may
case
control
enrol
follow
inclus
exclus
criteria
studi
tabl
case
defin
children
attend
pmh
cap
identifi
treat
clinician
oper
definit
pneumonia
studi
presenc
one
follow
clinic
symptom
cough
fever
increas
work
breath
b
alveolar
consolid
judg
treat
clinician
paediatr
radiologist
c
presum
infect
aetiolog
requir
antibiot
therapi
control
group
consist
contemporan
healthi
children
attend
pmh
outpati
clinic
local
commun
immunis
clinic
sign
respiratori
ill
total
case
control
enrol
power
studi
detect
significantli
higher
rate
pathogen
detect
among
case
versu
control
depend
frequenc
pathogen
detect
healthi
control
use
data
previous
publish
literatur
among
pneumonia
case
healthi
control
estim
sampl
size
pneumonia
case
healthi
control
would
provid
power
identifi
signific
excess
pathogen
case
identifi
daili
monitor
present
emerg
depart
ed
admiss
record
pmh
assess
inclus
exclus
criteria
parent
approach
train
research
assist
consent
enrol
follow
data
biolog
specimen
collect
control
enrol
prospect
contemporan
train
research
staff
attend
pmh
outpati
clinic
rheola
street
immunis
clinic
perth
western
australia
parent
approach
whilst
await
child
medic
appoint
routin
immun
control
frequenc
match
case
age
group
year
year
year
year
prospect
set
target
control
enrol
base
number
case
enrol
age
group
preced
two
week
follow
consent
epidemiolog
data
relat
pertin
demograph
factor
age
sex
indigen
statu
presenc
smoker
household
prematur
birth
preexist
chronic
health
condit
immunodefici
neurolog
disord
chronic
cardiac
diseas
collect
studi
particip
tabl
use
standard
paperbas
data
collect
form
interview
parent
data
clinic
manag
diseas
outcom
case
obtain
review
hospit
medic
record
patient
medic
record
file
revisit
obtain
miss
medic
inform
ill
episod
immun
record
child
collect
australian
immun
record
air
particip
alloc
uniqu
identif
number
allow
anonym
data
enter
onto
secur
webbas
research
databas
nasopharyng
swab
np
collect
case
control
use
floqswab
copan
diagnost
murrieta
ca
usa
train
research
staff
follow
recommend
procedur
collect
swab
store
skim
milktryptoneglucoseglycerol
broth
stggb
suitabl
storag
transport
respiratori
bacteria
virus
specimen
recommend
mandat
includ
blood
cultur
edta
blood
pneumococc
pcr
set
pleural
effus
cultur
pneumococc
pcr
also
recommend
despit
sensit
specif
lung
aspir
undertaken
pneumowa
given
invas
natur
risk
procedur
collect
np
specimen
kept
ice
process
within
research
laboratori
pmh
children
clinic
research
facil
ccrf
np
specimen
vortex
second
divid
two
aliquot
bacteri
viral
assess
vial
store
specimen
batch
period
sent
refer
laboratori
pcr
test
np
specimen
transport
refer
laboratori
ice
day
test
avoid
addit
freezethaw
cycl
nucleic
acid
standard
develop
use
purifi
plasmid
dna
vitro
transcrib
rna
concentr
dna
andor
rna
standard
quantifi
use
fluoresc
dye
follow
standard
curv
gener
serial
dilut
dna
andor
rna
standard
mention
viral
load
np
specimen
quantifi
interpol
appropri
standard
curv
viral
load
report
viral
copiesml
quantif
bacteri
load
np
specimen
perform
use
quantit
real
time
pcr
qpcr
use
method
establish
uwa
school
biomed
scienc
kirkham
l
et
al
unpublish
data
np
stgg
centrifug
high
speed
pellet
bacteria
associ
cell
dna
extract
pellet
use
enzymat
extract
qiaamp
dna
minikit
qiagen
chadston
vic
australia
previous
describ
realtim
qpcr
detect
pneumonia
aureu
catarrhali
nontyp
h
influenza
conduct
realtim
pcr
detect
system
biorad
ca
usa
use
primer
probe
list
tabl
standard
curv
gener
run
refer
strain
sampl
run
duplic
densiti
calcul
averag
two
measur
bacteri
load
assess
coloni
form
unit
cfu
ml
equival
copiesml
assum
one
copi
bacteria
would
yield
one
coloni
form
unit
frequenc
proport
posit
respiratori
pathogen
among
case
control
assess
number
permit
viru
subtyp
report
separ
proport
compar
across
two
group
identifi
specif
pathogen
detect
frequent
among
case
among
control
report
crude
oddsratio
detect
respiratori
pathogen
among
cap
case
versu
control
also
report
adjust
odd
ratio
pathogen
adjust
demograph
factor
eg
age
sex
presenc
smoker
household
prematur
birth
presenc
pathogen
use
multivari
logist
regress
refer
model
adjust
oddsratio
detect
among
case
versu
control
taken
indic
pathogen
organ
higher
oddsratio
higher
indic
pathogen
microorgan
use
proport
case
infect
adjust
oddsratio
pathogen
popul
level
attributablefract
cap
calcul
use
method
greenland
drescher
frequenc
proport
case
control
one
respiratori
viru
bacteria
detect
report
number
permit
multivari
regress
model
develop
explor
exist
signific
pairwis
interact
respiratori
pathogen
diseas
statu
diseas
sever
case
assess
use
respiratori
index
sever
children
score
risc
base
australian
children
growth
standard
number
permit
explor
relationship
detect
specif
pathogen
sever
diseas
versu
control
statu
use
multivari
logist
regress
model
describ
model
model
report
median
logtransform
pathogen
load
pathogen
case
control
compar
use
student
ttest
mannwhitney
utest
method
whichev
applic
determin
pathogen
load
differ
case
control
multivari
regress
analysi
model
perform
determin
odd
case
log
increas
pathogen
loadml
viral
bacteri
pathogen
adjust
demograph
factor
number
permit
approach
use
determin
increas
odd
sever
pneumonia
versu
control
statu
model
explor
receiveroper
curv
roc
correspond
area
curv
auc
find
optim
load
cutpoint
sensit
specif
discrimin
cap
case
control
sever
cap
nonsever
cap
pathogen
also
analys
data
use
classif
regress
tree
cart
bayesian
network
method
altern
approach
select
threshold
level
pathogen
load
discrimin
case
control
analys
perform
use
stata
softwar
version
statacorp
texa
usa
studi
approv
human
research
ethic
committe
princess
margaret
hospit
children
perth
australia
pmh
hrec
ref
written
inform
consent
obtain
parent
assent
children
year
prior
administr
questionnair
biolog
specimen
collect
risk
benefit
relat
particip
studi
clearli
inform
parent
children
obtain
consent
uniqu
identif
number
provid
particip
ensur
anonym
inform
collect
studi
particip
remain
confidenti
payment
compens
associ
particip
find
dissemin
nation
intern
confer
health
symposium
manuscript
detail
result
studi
submit
public
peerreview
journal
find
studi
would
describ
attribut
risk
specif
viral
bacteri
pathogen
caus
childhood
pneumonia
popul
level
might
help
effici
diagnosi
manag
lower
respiratori
tract
infect
lrti
includ
pneumonia
children
could
reduc
inappropri
antibiot
treat
lrti
fund
studi
provid
telethon
perth
children
hospit
research
fund
perth
children
hospit
foundat
telethon
kid
institut
none
ccb
conceiv
studi
tl
pcr
aj
rt
lk
dw
contribut
develop
mub
rw
implement
studi
activ
mlb
assist
recruit
laboratori
test
undertaken
tr
jl
cs
mub
draft
manuscript
author
review
manuscript
f
r
p
e
e
r
r
e
v
e
w
n
l
backgroundrational
explain
scientif
background
rational
investig
report
object
state
specif
object
includ
prespecifi
hypothes
present
key
element
studi
design
earli
paper
set
describ
set
locat
relev
date
includ
period
recruit
exposur
followup
data
collect
particip
give
elig
criteria
sourc
method
case
ascertain
control
select
give
rational
choic
case
control
n
l
give
sourc
fund
role
funder
present
studi
applic
origin
studi
present
articl
base
give
inform
separ
case
control
casecontrol
studi
applic
expos
unexpos
group
cohort
crosssect
studi
